Valneva announces new ixiaro® supply contract with the u.s. government worth a minimum of $32.8 million

Saint herblain (france), january 30, 2025 – valneva se (nasdaq: valn; euronext paris: vla), a specialty vaccine company, today announced the signing of a new $32.8 million contract with the united states (u.s.) department of defense (dod) for the supply of its japanese encephalitis (je) vaccine, ixiaro®.under this new one-year contract, the dod will buy a minimum of $32.8 million worth of ixiaro® vaccines and has the possibility to purchase additional doses during the coming twelve months. deliveries of ixiaro® doses have continued in 2024 under the supply contract signed in september 20231. the new contract will commence immediately.
VALN Ratings Summary
VALN Quant Ranking